We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Future of Dutch NGS-Based Newborn Screening: Exploring the Technical Possibilities and Assessment of a Variant Classification Strategy.
- Authors
Kiewiet, Gea; Westra, Dineke; de Boer, Eddy N.; van Berkel, Emma; Hofste, Tom G. J.; van Zweeden, Martine; Derks, Ronny C.; Leijsten, Nico F. A.; Ruiterkamp-Versteeg, Martina H. A.; Charbon, Bart; Johansson, Lennart; Bos-Kruizinga, Janneke; Veenstra, Inge J.; de Sain-van der Velden, Monique G. M.; Voorhoeve, Els; Heiner-Fokkema, M. Rebecca; van Spronsen, Francjan; Sikkema-Raddatz, Birgit; Nelen, Marcel
- Abstract
In this study, we compare next-generation sequencing (NGS) approaches (targeted panel (tNGS), whole exome sequencing (WES), and whole genome sequencing (WGS)) for application in newborn screening (NBS). DNA was extracted from dried blood spots (DBS) from 50 patients with genetically confirmed inherited metabolic disorders (IMDs) and 50 control samples. One hundred IMD-related genes were analyzed. Two data-filtering strategies were applied: one to detect only (likely) pathogenic ((L)P) variants, and one to detect (L)P variants in combination with variants of unknown significance (VUS). The variants were filtered and interpreted, defining true/false positives (TP/FP) and true/false negatives (TN/FN). The variant filtering strategies were assessed in a background cohort (BC) of 4833 individuals. Reliable results were obtained within 5 days. TP results (47 patient samples) for tNGS, WES, and WGS results were 33, 31, and 30, respectively, using the (L)P filtering, and 40, 40, and 38, respectively, when including VUS. FN results were 11, 13, and 14, respectively, excluding VUS, and 4, 4, and 6, when including VUS. The remaining FN were mainly samples with a homozygous VUS. All controls were TN. Three BC individuals showed a homozygous (L)P variant, all related to a variable, mild phenotype. The use of NGS-based workflows in NBS seems promising, although more knowledge of data handling, automated variant interpretation, and costs is needed before implementation.
- Subjects
NETHERLANDS; DNA analysis; NEWBORN screening; TURNAROUND time; BLOOD chemical analysis; ACADEMIC medical centers; RESEARCH funding; INBORN errors of metabolism; DIAGNOSTIC errors; EXPERIMENTAL design; TECHNOLOGY; GENE expression profiling; COMPARATIVE studies; SEQUENCE analysis; PHENOTYPES
- Publication
International Journal of Neonatal Screening (IJNS), 2024, Vol 10, Issue 1, p20
- ISSN
2409-515X
- Publication type
Article
- DOI
10.3390/ijns10010020